Plasma D Dimer: A Useful Marker of Fibrin Breakdown in Renal Failure

Summary

D dimer and other large fragments produced during the breakdown of crosslinked fibrin may be measured by enzyme immunoassay using monoclonal antibodies. In 91 patients with renal disease and varying degrees of renal dysfunction, plasma D dimer showed no correlation with renal function, whereas FgE antigen, a fibrinogen derivative which is known to be cleared in part by the kidney, showed a significant negative correlation with creatinine clearance. Plasma concentrations of D dimer were, however, increased in patients with chronic renal failure (244 ± 3l ng/ml) (mean ± SEM) and diabetic nephropathy (308 ± 74 ng/ml), when compared with healthy controls (96 ± 13 ng/ml), and grossly elevated in patients with acute renal failure (2,451 ± 1,007 ng/ml). The results indicate an increase in fibrin formation and lysis, and not simply reduced elimination of D dimer by the kidneys, and are further evidence of activated coagulation in renal disease. D dimer appears to be a useful marker of fibrin breakdown in renal failure.

Keywords

Renal failure - D dimer - Fibrin - Fibrinolysis

• References

• 1 Lane DA. Fibrinogen derivatives in plasma. Br J Haematol 1981; 47: 329-335
• 2 Merskey C, Johnson AJ, Lalezari P. Increase in fibrinogen and fibrin- related antigen in human serum due to in vitro lysis of fibrin by thrombin. J Clin Invest 1972; 51: 903-911
• 3 Gaffney PJ, Perry MJ. Unreliability of current serum fibrin degradation product (FDP) assays. Thromb Haemostas 1985; 53: 301-302
• 4 Gordon YB, Martin MJ, Landon J, Chard T. The development of radioimmunoassays for fibrinogen fragments D and E. Br J Haematol 1975; 29: 109-119
• 5 Nossel HL, Yudelman I, Canfield RE, Butler VP, Spanondis K, Wilner GD, Qureshi GD. Measurement of fibrinopeptide A in human blood. J Clin Invest 1974; 54: 43-53
• 6 Kudryk B, Robinson D, Netre C, Hessel B, Blombäck M, Blombäck B. Measurement in human blood of fibrinogen/fibrin fragments containing the β 15-42 sequence. Thromb Res 1982; 25: 277-291
• 7 Gaffney PJ, Lane DA, Kakkar VV, Brasher M. Characterisation of a soluble D dimer-E complex in crosslinked fibrin digests. Thromb Res 1975; 7: 89-99
• 8 Lane DA, Preston FE, VanRoss ME, Kakkar VV. Characterisation of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation. Br J Haematol 1978; 40: 609-615
• 9 Gaffney PJ, Creighton LJ, Perry MJ, Callus M, Thorpe R, Spitz M. Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). Br J Haematol 1988; 68: 83-90
• 10 Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, Whitaker AN, Elms M, Bunce I, Webber AJ, Wyatt D, Bundesen PG. An immunoassay for human D dimer using monoclonal antibodies. Thromb Res 1983; 31: 767-778
• 11 Depperman D, Andrassy K, Seeling H, Ritz E, Post D. β-thromboglobulin is elevated in renal failure without thrombosis. Thromb Res 1980; 17: 63-69
• 12 Parbtani A, Frampton G, Cameron JS. Measurement of platelet release substances in glomerulonephritis: a comparison of β-throm- boglobulin (BTG), platelet factor 4 (PF4) and serotonin assays. Thromb Res 1980; 19: 177-189
• 13 Lane DA, Ireland H, Knight I, Wolff S, Kyle P, Curtis JR. The significance of fibrinogen derivatives in human renal failure. Br J Haematol 1984; 56: 251-260
• 14 Ilo A, Rutherford WE, Wochner RD, Spilberg I, Sherman LA. The roles of renal catabolism and uraemia in modifying the clearance of fibrinogen and its degredative fragments D and E. J Lab Clin Med 1976; 87: 934-946
• 15 Lane DA, Markwick J, Thompson E, Ireland H. Experimental evidence for renal catabolism of fibrin fragment β 15-42. Thromb Res 1984; 33: 571-581
• 16 Purkerson ML, Hoffsten PE, Klahr S. Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int 1976; 9: 407-417
• 17 Ludlam CA, Cash JD. Studies on the liberation of β thromboglobulin from human platelets in vitro. Br J Haematol 1976; 33: 239-247
• 18 Whitaker AN, Elms MJ, Masci PP, Bundesen PG, Rylatt DB, Webber AJ, Bunce IH. Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies. J Clin Pathol 1984; 37: 882-887
• 19 von Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol (Basle) 1957; 17: 237-246
• 20 Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 1979; 16: 251-270
• 21 Martin KJ, Hruska KA, Lewis J, Anderson C, Slatopolsky E. The renal handling of parathyroid hormones. Role of peritubular uptake and glomerular filtration J Clin Invest 1977; 60: 808-814
• 22 Pizzo SV, Pasqua JJ. The clearance of human fibrinogen fragments D₁, D₂, D₃and fibrin fragment D₁ dimer in mice. Biochim Biophys Acta 1982; 718: 177-184
• 23 Briggs JD, Prentice CR M, Hutton MM, Kennedy AC, McNicol GP. Serum and urine fibrinogen-fibrin-related antigen (FR antigen) levels in renal disease. Br Med J 1972; 4: 82-85
• 24 Sakakibara K, Nagase M, Takada Y, Takada A. Relationship between urinary fibrinogen degradation products and various types of chronic nephritis. Thromb Res 1987; 45: 403-411
• 25 Kamitsuji H, Kusumoto K, Taira K, Iida Y, Nakajima M, Fukui H. Localization of intrarenal cross-linked fibrin in children with various renal diseases. Nephron 1983; 35: 94-99
• 26 Scott WL, Francis CW, Knutson DW, Marder VJ. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal transplantation. J Lab Clin Med 1986; 107: 534-543
• 27 Kamitsuji H, Whitworth JA, Dowling JP, Kincaid-Smith P. Urinary crosslinked fibrin degradation products in glomerular disease. Am J Kidney Dis 1986; 7: 452-455
• 28 Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. New Engl J Med 1988; 318: 1657-1666
• 29 Wardle EN. Fibrin in renal disease: functional considerations. Clin Nephrol 1974; 2: 85-92
• 30 Kessler CM, Bell WR. The effect of homologous thrombin and fibrinogen degradation products on fibrinogen synthesis in rabbits. J Lab Clin Med 1979; 93: 768-782
• 31 Franks JJ, Kirsch RE, Frith LO C, Purves LR, Franks WT, Mason P, Saunders SJ. Effect of fibrinogenolytic products D and E on fibrinogen and albumin synthesis in the rat. J Clin Invest 1981; 67: 575-580